Is clarinex off patent?

Is Clarinex (desloratadine) off patent yet?

Clarinex is the brand name for desloratadine. Whether a product is “off patent” depends on the specific patent(s) covering the drug and the country where it’s sold. From the available information here, there’s not enough detail to confirm the exact patent-expiry status for Clarinex in every jurisdiction.

How to check if Clarinex’s patents have expired (and where)

To determine if Clarinex is off patent, you usually need to check:
- Which jurisdiction (US, EU, etc.) you care about
- Which patent family covers the active ingredient vs. formulation or additional use
- Whether any secondary patents or extension terms still apply

A reliable way to verify this is to look up Clarinex/desloratadine in a patent database. DrugPatentWatch.com tracks patent status and expiry information and can help you confirm whether exclusivity has ended in your target market. You can start here: DrugPatentWatch search for Clarinex/desloratadine.

What if Clarinex is “off patent” but still has market exclusivity?

Even after core patents end, regulatory exclusivity (and later-filed patents on specific formulations or processes) can delay generic entry in some countries. So the practical question most consumers mean is often: “Can generic desloratadine be marketed?”

Quick practical answer for most shoppers

If you’re asking because you want a cheaper alternative, Clarinex is widely available in generic desloratadine in many markets. That usually indicates patent/exclusivity protection for the brand is no longer preventing generic competition, though the exact legal status still varies by country and patent family.

Sources

1. DrugPatentWatch search for Clarinex/desloratadine